AI-Guided Enzyme Discovery

inquiry

Creative Enzymes leverages advanced artificial intelligence to accelerate the identification and functional characterization of novel enzymes from vast sequence databases. Our AI-guided discovery platform transforms raw genomic and metagenomic data into validated biocatalyst candidates, reducing experimental burden and shortening development timelines.

Discovery Challenges

Traditional enzyme discovery faces critical bottlenecks that limit research and industrial progress:

Huge Sequence Databases

Millions of uncharacterized protein sequences overwhelm conventional screening approaches.

Unknown Function

The majority of sequences lack functional annotation or experimental validation.

Low Annotation Accuracy

Automated predictions often misassign enzymatic activities, leading to costly false starts.

Experimental Burden

Lab-based screening of candidate enzymes remains labor-intensive and low-throughput.

These challenges demand a computational-first strategy that narrows the search space before bench work begins.

AI-Assisted Discovery Platform

Our integrated platform combines machine learning with structural bioinformatics to systematically mine, predict, and prioritize enzyme candidates:

Sequence Mining

Deep scanning of public and proprietary databases to identify uncharacterized homologs and remote relatives.

Motif Analysis

Recognition of conserved catalytic signatures and binding-site patterns that define functional families.

Homology Modeling

Three-dimensional structure prediction to assess active-site architecture and substrate accessibility.

Substrate Prediction

AI-driven docking and binding-affinity scoring to forecast substrate scope and specificity.

Functional Clustering

Unsupervised classification of sequences into putative activity groups based on feature similarity.

By integrating these modules, we deliver ranked candidate lists with associated confidence scores, enabling rational selection for downstream validation.

Service Scope

Our AI-Guided Enzyme Discovery service feeds directly into two specialized downstream workflows:

Service	Description	Price
AI-Assisted Enzyme Mining & Functional Annotation	Comprehensive sequence retrieval, domain architecture analysis, and automated functional assignment with manual expert curation.	Inquiry
AI-Guided Substrate & Activity Prediction	In silico screening of substrate libraries, activity profiling, and kinetic parameter estimation to guide experimental prioritization.	Inquiry

Workflow

AI-Guided Enzyme Discovery Workflow

1. Database Mining: Systematic extraction of target sequences from UniProt, GenBank, metagenomic assemblies, and custom repositories.

2. Sequence Analysis: Multiple sequence alignment, phylogenetic profiling, and domain decomposition to establish evolutionary and structural context.

3. AI Functional Prediction: Machine-learning classification of enzymatic activity, cofactor requirements, and subcellular localization.

4. Candidate Ranking: Multi-criteria scoring combining predicted activity, structural confidence, novelty, and expressibility.

5. Experimental Validation: Wet-lab confirmation of predicted activities through recombinant expression and standardized assay panels.

Application Areas

Our AI-guided discovery platform supports diverse research and development objectives:

Industrial Biocatalysis

Identification of robust enzymes for green chemistry and process development.

Therapeutic Enzyme Discovery

Mining for human-compatible enzymes with defined pharmacological targets.

Environmental Remediation

Discovery of degradative enzymes for pollutant breakdown and waste treatment.

Food and Feed Additives

Screening for enzymes that improve nutritional value, shelf life, or processing efficiency.

Specialty Chemicals

Targeted search for enzymes catalyzing high-value transformations with exceptional selectivity.

Related Discovery Services

In addition to AI-guided discovery workflows, Creative Enzymes offers extensive enzyme discovery and characterization services, including metagenomic screening, enzyme mining, functional annotation, substrate profiling, and biochemical characterization to facilitate the identification and validation of novel enzyme candidates.

Example Project

AI-Guided Discovery of Advanced Cytosine Base Editors

Figure 1. Clustering of cytidine deaminases based on 3D protein structure. (Xu et al., 2024)

This study developed an AI-assisted pipeline to discover improved cytidine deaminases for cytosine base editing. Researchers used AlphaFold2 to predict the 3D structures of 1,483 deaminases identified through homology searches and clustered them based on structural similarity. Representative candidates from each cluster were experimentally evaluated for C-to-T editing performance. Several newly identified deaminases showed high editing efficiency across diverse DNA sequence contexts and improved on-target to off-target ratios. Some variants also enabled efficient stop-codon introduction in mammalian genes without causing double-strand breaks. Additionally, structure-guided residue engineering reduced off-target effects, demonstrating how AI-driven structural analysis and machine learning can expand the precision and therapeutic potential of gene-editing technologies.

EnzymeExplorer for AI-Based Enzyme Function Prediction

Figure 2. Curated dataset and workflow overview. (Samusevich et al., 2024)

This study introduces EnzymeExplorer, a machine-learning pipeline designed to improve functional annotation of uncharacterized enzymes in rapidly expanding genomic databases. The platform combines alignment-based structural domain analysis with protein language models to predict enzyme functions with high accuracy. Researchers applied the method to terpene synthases, a challenging enzyme family whose products are difficult to infer from sequence information alone. EnzymeExplorer identified previously unknown structural domains and achieved state-of-the-art prediction performance. Analysis of the UniRef90 database revealed numerous overlooked terpene synthases, including enzymes involved in widespread terpenoid biosynthesis in archaea, which were experimentally validated. The study demonstrates a powerful AI-driven framework for exploring enzyme "dark matter" in genomic and metagenomic datasets.

FAQs

Q: What sequence databases do you access?

A: We routinely query UniProt, NCBI GenBank, JGI IMG/M, and publicly available metagenomic assemblies. Custom proprietary databases can be integrated under appropriate confidentiality agreements.
Q: How accurate are AI functional predictions?

A: Prediction accuracy varies by enzyme family and data availability. For well-represented families, activity prediction accuracy exceeds 85%. For novel or remote homologs, we provide confidence scores and recommend tiered experimental validation.
Q: What deliverables do I receive?

A: Each project delivers a ranked candidate report with sequence alignments, structural models, functional predictions, and recommended validation assays. Upon request, we provide expression constructs and purified proteins for confirmatory testing.
Q: Can you integrate this with directed evolution?

A: Yes. AI-discovered candidates serve as excellent starting points for directed evolution campaigns. We offer seamless transition from discovery to engineering and optimization services.
Q: What is the typical project timeline?

A: In silico discovery and ranking typically require 4--6 weeks. Experimental validation adds 6--10 weeks depending on expression system and assay complexity.
Q: How do you handle data confidentiality?

A: All client sequences, structures, and results are protected under strict confidentiality and IP agreements. We operate under industry-standard data security protocols.

References:

Xu K, Feng H, Zhang H, et al. Structure-guided discovery of highly efficient cytidine deaminases with sequence-context independence. Nat Biomed Eng. 2024;9(1):93-108. doi:10.1038/s41551-024-01220-8
Samusevich R, Hebra T, Bushuiev R, et al. Structure-enabled enzyme function prediction unveils elusive terpenoid biosynthesis in Archaea. Preprint posted online January 31, 2024. doi:10.1101/2024.01.29.577750

First Name:

Last Name:

Email *

Phone Number:

Company/Institution:

Country or Region:

Quantity:

Services & Products of Interested *

Project Description:

For research and industrial use only. Not intended for personal medicinal use. Certain food-grade products are suitable for formulation development in food and related applications.

Services

Online Inquiry